Marcyrl
Entry
2023
Hold
3yr
Status
Active
Who owns Marcyrl?
Marcyrl is a Pharma company based in Egypt, currently owned by Amethis since 2023 and Edmond de Rothschild Private Equity (France).
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
Edmond de Rothschild Private Equity (France)Amethis Fund III · 2023 · Growth
2 ownership periods · full history below
Key facts
HQEgypt
SectorPharma
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2023 · present
AmethisActive
2023 · present(3yr) · Amethis MENA Fund II · 2022 · Growth
More from Amethis Fund III
Other portfolio companies in the same fund.
FranceMore PE-backed in Pharma
Comparable pharma deals from other GPs.
US
SpainQuestions
Who owns Marcyrl?
Marcyrl is currently owned by Amethis and Edmond de Rothschild Private Equity (France), through Amethis Fund III, since 2023.
When did Amethis and 1 other acquire Marcyrl?
Amethis and 1 other acquired Marcyrl in 2023.
Who has owned Marcyrl over time?
Marcyrl has been through 2 private-equity ownership periods: Amethis · via Amethis MENA Fund II · since 2023; Edmond de Rothschild Private Equity (France) · via Amethis Fund III · since 2023.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue